Literature DB >> 6440920

[Comparative clinical study of ofloxacin and cefaclor in bacterial bronchitis].

I Fujimori, Y Kobayashi, M Obana, A Saito, M Tomizawa, I Nakayama, Y Hiraga, K Kikuchi, A Yamamoto, K Takebe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6440920     DOI： 10.11150/kansenshogakuzasshi1970.58.832

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN： 0387-5911


× No keyword cloud information.
  5 in total

1.  [Documentation and assessment of adverse drug effects with ofloxacin as an example].

Authors:  B Esch; N Paeschke; W Christ; G Kreutz
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

3.  Ofloxacin in respiratory tract infection. A review of the results of clinical trials in Japan.

Authors:  A Saito; M Katsu; A Saito; R Soejima
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 4.  Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.

Authors:  J P Thys; F Jacobs; B Byl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 5.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.